Ligand validation:9ATM

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 9ATM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9ATM_NAG_R_602	2%	77%	0.155	0.391	0.37	0.54	-	-	0	0	100%	0.8
7ZF7_NAG_A_804	31%	79%	0.181	0.848	0.24	0.61	-	-	0	0	100%	1
7ZF9_NAG_E_601	16%	89%	0.256	0.825	0.25	0.38	-	-	0	0	100%	1
7XB0_NAG_A_703	6%	68%	0.227	0.659	0.24	0.99	-	1	2	0	100%	1
8S6M_NAG_R_604	3%	87%	0.242	0.556	0.23	0.46	-	-	0	0	100%	0.5
7ZXU_NAG_E_605	1%	90%	0.291	0.49	0.27	0.33	-	-	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.